Table 2.
Main echocardiographic measures at follow-up (median time 66 months, IQR 19–126) in the overall subset of patients with available follow-up reassessment and divided according to proband status.
total n=68 |
probands n=28 (57%) |
non-probands n=21 (43%) |
p-value | |
---|---|---|---|---|
Echo LVEF (%) | 44±14 | 38±14 | 49±12 | 0.001 |
Echo LVEF <50 (%) | 57 | 78 | 39 | 0.001 |
Echo LVEF ≦35 (%) | 25 | 37 | 14 | 0.025 |
Echo LVEDD (mm) | 60±10 | 63±9 | 55±10 | 0.008 |
Echo RVFAC (%) | 41±9 | 41±10 | 40±8 | 0.710 |
Echo RVFAC<35 (%) | 14 | 17 | 11 | 0.505 |
Echo MR (%) | 64 | 71 | 55 | 0.277 |
For abbreviations see Table 1